Questioning the methodologic superiority of 'placebo' over 'active' controlled trials. - Wikidata - wikimedia - TriplyDB

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

http://www.wikidata.org/entity/Q35016839

about

Are treatments more effective than placebos? A systematic review and meta-analysis Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.Photoelectric stimulation of defined ear points (Smokex-Pro method) as an aid for smoking cessation: a prospective observational 2-year study with 156 smokers in a primary care setting.Placebo use in the United kingdom: results from a national survey of primary care practitioners The ethics of clinical trials Patient preferences and performance bias in a weight loss trial with a usual care arm.What questions can a placebo answer?Compellingness: assessing the practical relevance of clinical research results.Problematic placebos in physical therapy trials.Placebo orthodoxy and the double standard of care in multinational clinical research.Placebo Controlled Trials: Interests of Subjects versus Interests of Drug Regulators.Are explanatory trials ethical? Shifting the burden of justification in clinical trial design.Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution.Knowledge and Belief in Placebo Effect.Questioning the methodological superiority of 'placebo' over 'active' controlled trials.Research, medicine, and "placebos".Strengthening Howick's argument against the alleged superiority of placebo-controlled trials.Who's in control of the choice of control?Conflating scientific with clinical considerations.A clinical perspective on placebo research: looking back, looking forward.Placebo misconceptions.Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials.The rationale for placebo-controlled trials: methodology and policy considerations.Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentaries.Evidence-based mechanistic reasoning.‘Placebos’ and the logic of placebo comparison Ethical Issues in the Difference Between Placebo-Controlled and Active-Controlled Trials

P2860

Q21559660-891EC7F8-8A10-4832-819C-444150286D93 Q30533987-2EF1E6FE-FECE-458B-A390-C78228023535 Q34017413-BB801C96-2402-43CD-9CE4-E11B77A1A8F8 Q34335161-5DC2A9A2-0AAB-4811-B61C-4E0F7D083F1B Q37488194-B10166FE-3F19-4084-A346-B53BEC175159 Q37714855-58CAB461-F587-482B-B31A-7462C6F81610 Q38836479-11A738E4-326D-4343-B0CA-1FFD9620895E Q39549916-ADDCD961-3FFF-42D9-A403-28270C0F67A1 Q39708679-108D7664-8246-4430-BD0A-9D37C793D5A6 Q41495263-1E9BCC60-F662-414F-ABFA-506EA39E6C71 Q42362568-6BBF0E32-2EA7-4520-BEAF-C986B3752404 Q44619863-ABB3361F-6B39-4F91-9A8C-A2EDEFDF54DA Q46382331-C58C191B-2805-4893-BF5F-C5F0968E0833 Q47608244-432BFE63-6EA3-4752-BCB7-1FBE32118F01 Q48935968-1FA48A36-B820-4615-A1F5-8E04F28060A7 Q48935988-A1194F9C-75E9-41F0-A5E7-DA95C162FA2E Q48936004-50EA86EF-A474-445F-A6A7-8B73D27353E6 Q48936017-47BD66AC-D7E8-40FF-8B68-449245F387DE Q48936041-12D93041-B7DE-4BEF-9767-29C2D13BFD58 Q48936061-E55BD116-1568-4F1A-987D-ED0B8553E086 Q48936076-F20B983F-B9EB-46E8-B30A-BCFD6F8ABE2A Q48936131-BB68487E-808D-47D6-B572-55A32ECBECB8 Q48936166-D8708BE4-847A-4045-986F-691A179A1EA8 Q48936365-212EADD6-B0AB-469D-8BFA-17F5E6518C31 Q51896797-C22E858B-1A46-42CF-8367-882FDCB7F72F Q55980444-2B8C7F23-BB45-43ED-A673-98B1498DD7FF Q57989648-BF204C96-F53C-44FC-AB6C-08254DF61DDD

P2860

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

http://www.wikidata.org/entity/Q35016839

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@ast

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@en

type

label

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@ast

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@en

prefLabel

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@ast

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@en

P1433

Q35016839-CC5E4846-BEA7-4B93-A100-00B18233F9E3

P1476

Q35016839-2E5DBD2F-F8E8-4363-A335-FCEFECE2DB79

P2860

Q35016839-0164B4AA-8508-44B8-96E0-53CCA4E855EB

Q35016839-08C1AAAF-6592-4908-BFD7-6119402F2D56

Q35016839-1948CDD2-44FC-4955-BCCB-CBBC7D05EF58

Q35016839-240B0660-DC7C-41AC-AD6C-716F63C16D11

Q35016839-2B83A1AA-5734-4D98-B852-E31B1AE4DDB9

Q35016839-2C6BC942-13F8-4D8C-ABAF-775ED4788A05

Q35016839-2D8E29B3-7B8A-4E9E-A895-96A465AE5C25

Q35016839-2FCE0BCE-8BD7-41AA-93A7-AA601934864D

Q35016839-3B27AF6F-2CDD-4AD3-85A8-8F69066021D3

Q35016839-3EB7DDAE-4665-4692-BDBF-3AEDAEFE90A9

P304

Q35016839-94794DC2-87B3-4F11-94DF-D048BAF9BC0D

P31

Q35016839-CF182A80-4F7C-4EF0-84D1-01280157778F

P356

Q35016839-1212D168-EDE6-402B-BC4E-B3263495C261

P433

Q35016839-21DB1603-2283-47BB-8C4C-9D821342A3A1

P478

Q35016839-D1AD53C7-E1F3-430B-96A0-3AF1A5D34002

P50

Q35016839-4641B0FC-DBD7-4FD8-BA03-B965AD0D24D5

P577

Q35016839-610BB7AD-8ACE-4089-8C0C-8D686F9C3CEB

P5875

Q35016839-FC4B4878-FFCE-4AE2-93F1-EB3CDA4FDAA7

P698

Q35016839-0D1552B9-E3F3-4057-B324-FED8B75F3937

P921

Q35016839-A8585EB2-FA25-4036-BDDF-6475F0FFA511

P356

15265160903090041

P1433

American Journal of Bioethics

P1476

Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.

@en

P2860

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

Placebo effects: clinical aspects and neurobiology

Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Statistical Methods in Medical Research

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials

Placebo analgesia: findings from brain imaging studies and emerging hypotheses.

P304

34-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15265160903090041

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40485007

http://www.w3.org/2001/XMLSchema#string

P698

19998192

http://www.w3.org/2001/XMLSchema#string

P921